Dr. Adamson is the Director of Fertility Physicians of Northern California and the Fertility and Reproductive Health Institute, a Clinical Professor at Stanford University School of Medicine, and Associate Clinical Professor at U.C. San Francisco School of Medicine.
He is also President of ICMART (International Committee for Monitoring Assisted Reproductive Technologies) and WERF (World Endometriosis Research Foundation), and Reproductive Medicine Expert to WHO (World Health Organization).
Sutter Health Research Enterprise
540 University Avenue
Suite 200
Palo Alto, CA, 94301
(800) 597-2234
adamsogd@sutterhealth.org
Publications
Improved implantation rates of day 3 embryo transfers with the use of an automated time-lapse-enabled test to aid in embryo selection.
Demonstrate improved implantation rates in patients receiving day 3 embryo transfers based on the combined use of a time-lapse test and traditional morphology.
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research.
Std recommended and min required questionnaires focus on pelvic pain, subfertility, menstrual/reproductive history, hormone/med use, med hx, and personal info.
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research.
Developed recommended std and min required SOPs for the collection, processing, storage of plasma, serum, saliva, urine, endometrial/peritoneal fluid.
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research.
Developed "recommended std" and "minimum required" SOPs for the collection, processing, storage of ectopic and eutopic endometrium, peritoneum, and myometrium.
International Committee for Monitoring Assisted Reproductive Technologies: World Report on Assisted Reproductive Technologies, 2007.
The international trend toward <3 transferred embryos continued, as did the wider uptake of FET. This was achieved without compromising delivery rates. The application of ART for women aged >40 years was a major component of ART services in some regions and countries.
Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan.
Frozen-thawed BT is associated with improved general perinatal outcomes of pregnancy but significantly increased maternal risks of placenta accreta and PIH.
A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.
SC progesterone represents a novel option for luteal phase support in women undergoing IVF who prefer not to use a vaginal preparation.
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research.
First multicenter, international collaboration between academic centers and industry addressing standardization of phenotypic data collection for a disease.
International Committee for Monitoring Assisted Reproductive Technologies World Report: Assisted Reproductive Technology 2006.
Adopting the policy of SET, FET and the cessation of transferring more than two embryos should be widely applied.
The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis.
Relative cost that consumers pay for ART treatment predicts the level of access and number of embryos transferred.
The International Glossary on Infertility and Fertility Care, 2017.
A consensus-based and evidence-driven set of 283 terminologies used in infertility and fertility care was generated to harmonize communication among health professionals and scientists as well as the lay public, patients and policy makers.
World Endometriosis Society consensus on the classification of endometriosis.
Large, global, consortium of 29 major stakeholding organizations from 19 countries convened to evaluate evidence on endometriosis classification.
Research priorities for endometriosis: recommendations from a global consortium of investigators in endometriosis.
New areas in the 2014 recommendations included infertility, pt. stratification, research in emerging nations, and more focus on translational research.
Cross-border reproductive care in North America: a pilot study testing a prospective data collection program for in vitro fertilization clinics in Canada and the United States.
Although cross-border reprod care is a major component of assisted reproductive technology in No Am, clinicians are not motivated to collect data on these pts.
An open letter to the Food and Drug Administration regarding the use of morcellation procedures in women having surgery for presumed uterine myomas.
An open letter to the Food and Drug Administration regarding the use of morcellation procedures in women having surgery for presumed uterine myomas.
A success story: impact of the United States in vitro fertilization data registry on advancing fertility care.
SART data collection, analysis, and annual reporting has been very successful in providing data on clinical effectiveness, quality of care, and safety.
International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011.
Global assisted reproductive technology utilization, effectiveness, and safety increased between 2010 and 2011.
An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis.
Evidence suggests that clinical dx of endometriosis is more reliable than previously recognized Surgical dx has limitations that could be underappreciated.